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Abstract
The efficient and effective movement of research into practice is acknowledged as crucial
to improving population health and assuring return on investment in healthcare research.
The National Center for Advancing Translational Science which sponsors Clinical and
Translational Science Awards (CTSA) recognizes that dissemination and implementation
(D&I) sciences have matured over the last 15 years and are central to its goals to shift academic health institutions to better align with this reality. In 2016, the CTSA Collaboration and
Engagement Domain Task Force chartered a D&I Science Workgroup to explore the role of
D&I sciences across the translational research spectrum. This special communication discusses the conceptual distinctions and purposes of dissemination, implementation, and translational sciences. We propose an integrated framework and provide real-world examples for
articulating the role of D&I sciences within and across all of the translational research
spectrum. The framework’s major proposition is that it situates D&I sciences as targeted
“sub-sciences” of translational science to be used by CTSAs, and others, to identify and
investigate coherent strategies for more routinely and proactively accelerating research
translation. The framework highlights the importance of D&I thought leaders in extending
D&I principles to all research stages.

Translational research means different things to different people, but it seems important to almost everyone.
—Steven Woolf (Woolf, 2008)

Introduction
The National Center for Advancing Translational Science (NCATS) was established in 2012
with the goal of hastening the scientific process required to develop and deliver treatments that
improve people’s lives. Its purpose is to advance understanding and routine use of translational
science; that is, the science concerned with the process of “translation.” Translation has been
defined as the problem-oriented practical process of “turning observations in the laboratory,
clinic, and community into interventions that improve the health of individuals and the public”
[1]. Whereas traditional conceptualizations of science are primarily concerned with the creation
of new knowledge, translational science is ultimately concerned with the process of solving –
through application of research knowledge – health-related problems. Thus, translational
science seeks to understand the “scientific and operational principles” underlying each step
of the translational process [1].
To operationalize the advancement of translational science, the Centers for Translational
Science Awards (CTSA) Program has funded – since 2006 – the activities of a consortium of
more than 60 academic medical centers, referred to as CTSAs, or “hubs” [2,3]. Within and
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Fig. 1. The Integrative Framework of Dissemination, Implementation, and Translation (IFDIT).

across these CTSA hubs, investigators and clinicians at all stages
of the translational research spectrum work together to develop,
demonstrate, and disseminate strategies for overcoming common
barriers to efficient and effective translation.
Ultimately, the aim of translational science is to identify guiding principles for improving the efficiency and effectiveness of
research translation. One can imagine several ways in which
insights gained from the sciences of dissemination and implementation (D&I) could be adapted to support this aim and
enhance translation [4]. For this reason, in 2016, the CTSA consortium’s Collaboration and Engagement Domain Task Force
chartered a dissemination, implementation, and knowledge
translation workgroup. This special communication is a product
of that workgroup.

Objective
Specifically, the objectives of our workgroup were to (1) communicate the ways in which the sciences of dissemination, implementation, and translation relate and (2) explore the role of CTSAs in
supporting and advancing these interrelated sciences. In pursuing
these objectives, we determined that a new framework would be
helpful in promoting synergy among the sciences and ensuring
that the strengths of each are used to advance the work of
CTSAs. As such, we also introduce the Integrative Framework
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of Dissemination, Implementation and Translation (IFDIT)
(Fig. 1) as a guide CTSA hubs can use to support their individual
and collective efforts to advance translation and improve population health.
The Three Sciences: Dissemination, Implementation, and
Translational
The National Institutes of Health (NIH) defines dissemination
as the active and targeted distribution of information and intervention materials to a specific public health or clinical practice
audience [4]. Dissemination research is defined as the scientific
study of this phenomenon, and its goal is to expand our understanding of how best to spread the knowledge required to adopt
and deploy evidence-based interventions [5]. Contemporary
investigators conducting dissemination research aim to identify
approaches to packaging and conveying information to improve
clinical care, community, and public health services [6,7].
NIH defines implementation as the adoption and integration of
evidence-based health interventions into clinical and community
settings for the purposes of improving care delivery and efficiency,
patient outcomes, and individual and population health [5].
Implementation research is the scientific study of this process,
and its goal is to develop a knowledge base about “how” interventions become normalized and embedded within real-world
practice settings and patient populations [5].
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Table 1. Extending D&I principles to early-stage translational research
Principles from D&I
sciences
Context matters and is
multi-level

Implications for late-stage research

Rationale for role in early-stage research

Successful dissemination of research knowledge and
All research, including basic and pre-clinical, is conducted and
implementation of scientific discoveries are profoundly affected translated within a complex multi-level context
by healthcare policy, organizational and
community culture and climate, and attitudes and
behaviors of key stakeholders

Intervention design and development benefits from
It is not sufficient that
We must be equally concerned with whether evidence can
appreciation of the factors that influence later-stage
evidence exists and/or be disseminated to reach key stakeholders and whether
adoption and implementation, such as usability, desirability,
a practice works
practices can be taken up and delivered in real-world settings.
feasibility, and cost
This compels accompanying lines of inquiry
Change happens
proactively

To facilitate the adoption, spread, and sustainment of improved Even in the early stages of research, people working in systems
diagnostics, therapeutic, and service delivery interventions,
decide what research will be pursued and how
strategies must be developed, used, and continually improved
it will be done. Strategies that influence behaviors and social
through scientific inquiry
relationships are relevant

Both implementation
practice and
implementation science are
team endeavors

Implementation practice requires iterative engagement and
The bidirectional exchange of information and perspectives
involvement of a range of stakeholders, including patients,
between stages and disciplines improves the likelihood that
clinicians, administrators, researchers, and policymakers.
research products will bridge translational gaps. This is true
Similarly, implementation science is inherently transdisciplinary, even in early stages of research
involving treatment developers and researchers, health services
researchers, and experts from closely related fields such as
industrial psychology and communications research

D&I, dissemination and implementation.

D&I research is informed and guided by underlying sciences
[8,9] that share a common origin. These sciences trace their roots
back to at least the early 1900s and to work from European and
American sociologists that described the process of social change
as a diffusion of ideas and innovations among individual adopters
[10]. More recently, it has become clear that dissemination and
implementation are separate but related processes that often
co-occur (implementation following dissemination). Some argue
that the D&I sciences are in fact different perspectives of the same
parent science [11,12]. In the opinion of our workgroup and NIH,
the two sciences are related but distinct, with each providing
unique contributions to the translational process.
As mentioned above, NCATS defines translation as the process
of turning observations into interventions that improve health [1].
Translational research is focused on leveraging facilitators and
overcoming specific barriers to achieve this end. Translational
science is concerned with identifying and advancing generalizable
principles that hasten research translation. Translational science as
a term is newer than the D&I sciences, emerging only in the last 20
years and in response to pressures to make research more useful
[13]. Its explicit focus has been on increasing the efficiency and
effectiveness of moving research from one stage to the next so that
useful and timely research products are made available for D&I [1].
The Integrating Principles
To investigators with exposure to and experience with all three
sciences, it is clear that the sciences of dissemination, implementation, and translation are related (see Table 1). All three are concerned with solving real-world problems that impact population
health, yet all three are still sciences – focused on deriving solutions
that are theoretically based, generalizable, rigorously tested, reproducible, and transferable. Moreover, as is increasingly recognized,
all three sciences are bidirectional. In the case of translational
science, for example, observations in practice and community settings inform the research that should be conducted in the lab and
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in early phase human trials and vice versa. In D&I sciences, strategies are used to hasten the adoption and use of translational
research products, while insights gained from understanding the
contexts of practice and community settings are also used to
inform the early phase selection and crafting of adoptable and
usable interventions [14]. For example, brief educational meetings
and audit and feedback reports are strategies that might be used to
support the late-stage adoption of a clinical decision support tool,
but the tool itself was first made adoptable (in early-stage research)
by developing an understanding of the clinical workflow and the
needs of busy clinicians. In short, the sciences of dissemination,
implementation, and translation are each consistent with the ideals
and function of a learning health care system – they are tools that
are used to efficiently collect and apply insight to improve health.
Typically, they do this through observation and the engagement
of stakeholders, and through the use of diverse, often behavioral
strategies designed to influence what people (e.g. researchers in
translational science, and patients and practitioners in D&I) do.
In a practical sense, the sciences do this work by focusing on
identifying and overcoming barriers. Traditionally, translational
science has focused on barriers to intervention development while
D&I sciences have focused on barriers to intervention adoption
and use. These conceptualizations, while useful and accurate
descriptions of present realities, likely limit understanding of the
full applicability of the sciences and preclude key opportunities
for synergy. For example, when translation is defined only as
“the process of turning observations into interventions,” [1] there
is an assumption that “improvement in health” will be achieved by
developing effective interventions alone, and that D&I barriers will
be overcome naturally – despite a large body of evidence showing
this is not the case [15–20]. Similarly, D&I sciences, in their effort
to understand how best to scale up evidence-based practices, may
fail to appreciate barriers to efficiently building strong, generalizable evidence and useful and usable interventions worth disseminating and implementing, as well as the role that the applicability
and quality of evidence plays in the success of D&I efforts.
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Table 2. Example strategies and uses of D&I to improve the translational process of research conduct within each research stage
IFDIT stage objective

Research method
and output

Potential use of
translational science

Basic research

To determine whether Basic and pre-clinical
targets, markers, or
studies that generate
pathways exist
knowledge about new
targets, markers, or
pathways

Pre-clinical
research

To determine whether Phase 1 trials that generate Advance novel study
designs that
knowledge about whether
target, marker, or
improve the
interventions work in
pathway can be
efficiency of
humans
influenced in
phase 1 trials
humans

Clinical research

To determine whether Phase 2 and 3 trials that
interventions are
generate knowledge
effective in patients
about whether
interventions help
patients

Potential use of
dissemination science

Develop lab registries Seek to understand social
and open science
pressures among basic
models that share
scientists that inform
insights and avoid
the research questions
unnecessary
they pursue
duplication of
efforts

Potential use of
implementation science
Study the effect of
strategies to improve
routine use of efficient,
best practice lab
procedures among staff

Apply marketing principles Use behavioral economic
strategies to improve
to inform participant
participant engagement
recruitment strategies
and retention in trials
to trials
Utilize key opinions
leaders to optimize
communication among
study teams at multiple
sites

Use audit and feedback to
improve adherence to
study protocols among
study teams

Clinical
To determine whether Phase 4 and pragmatic trials Develop clinical and
practice-based
that generate knowledge
implementation
interventions can
research networks
about whether
be effectively
that can respond
interventions help
delivered in
quickly to conduct
patients in practice and
practice
T3 research
how to implement them
in these settings

Conduct studies to
ascertain optimal
strategy for
disseminating evidence
to improve intervention
adoption and reach

Conduct studies to identify
and reduce key barriers
to adopting and
implementing in routine
practice, and to reduce
disparities in
implementation

Public health

Conduct comparative
studies of different
dissemination strategies
to determine most costeffective method of
reaching target settings
and audiences

Conduct comparative
studies of different
implementation
strategies to determine
most cost-effective
method of sustainably
implementing in target
settings

To determine whether Observational, outcomebased studies and
interventions can
implementation research
be effectively
that generate knowledge
delivered to
about whether and how
improve population
health
interventions improve
population health

Develop multi-site
IRBs and other
infrastructures to
increase study
efficiency

Develop informatics
approaches and
big data practices
to efficiently
monitor effects
of wide-spread
intervention
roll-out

D&I, dissemination and implementation; IFDIT, Integrative Framework of Dissemination, Implementation and Translation.

Finally, all three sciences are consistent with CTSA objectives
to create generalizable knowledge and to identify broadly useful
practices and principles. The rationale for generating products of
this type is that their application has pragmatic value. Yet,
differences exist among the sciences in this regard. Specifically,
only translational science has communicated an explicit role
for itself within all phases (e.g. T1–T4) of the research spectrum
[21]. D&I sciences, in contrast, have been mostly limited in their
application to the late-stage phases of research in which a viable
intervention exists. This may represent a missed opportunity to
leverage knowledge from decades of D&I research on how to
optimize complex, real-world processes to advance translational
efforts across the research spectrum. Specifically, Table 1 shows
how principles that consistently guide D&I efforts within
later translational research stages can find a constructive role
in basic and pre-clinical research as well. Tables 2 and 3 provide
examples.
The Integrative Framework of Dissemination,
Implementation, and Translation
Finally, we present the IFDIT in Fig. 1. The IFDIT seeks to integrate and expand current understanding and practice related to the
dissemination, implementation, and translational sciences in order
to optimize their contributions into a cohesive framework for
translational activities and research. It uses as its basis an NCATS
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conceptualization which represents the translational research
spectrum as a set of five interconnected and non-linear circular
stages connecting basic research, pre-clinical research, clinical
research, clinical implementation, and public health [22] (some
rights reserved: https://creativecommons.org/licenses/by/2.0/).
Each stage builds upon and informs each of the others via bidirectional relationships and all the stages center on and are assumed to
benefit from a commitment to broad stakeholder engagement.
Upon this foundation, the IFDIT adds a conceptualization of translation as a pair of processes that occur both within and between
translational stages. The process that occurs within each of the five
stages is termed research conduct, and it consists of the practical
matters of carrying out a research study and generating new
knowledge (e.g., formulating a research question, collecting and
analyzing data, drawing conclusions). The process that occurs
between the stages (via the 10 connecting lines) is termed research
application, and it consists of the practical matters of using this new
knowledge to guide the development of interventions, conduct
other research, and ultimately improve health. Conceptualizing
translation in this way – as a pair of processes – is intended both
to (1) support targeted efforts to overcoming specific barriers
within and between particular stages (e.g. by focusing on the
unique goals of that stage or gap) and to (2) clarify opportunities
for advancing a generalizable science of translation (e.g. by focusing on the larger conceptual issues of the underlying process, either
research conduct or application).
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Table 3. Example strategies and uses of D&I to improve the translational process of research application between translational stages
IFDIT interstage gap
objective

Potential use of
translational science

Potential use of
dissemination science
Compare strategies for
disseminating evidence from
basic research to potentially
receptive pre-clinical
research centers

Potential use of
implementation science

Potential synergizing
application of all
three sciences

Basic research
to pre-clinical
research

To have
knowledge
about a
potential
therapeutic
target tried
in humans

Develop phased funding
mechanisms to preemptively pair preclinical scientists and
phase 1 trialists

Pre-clinical
research
to clinical
research

To have
knowledge
about an
efficacious
intervention
in humans
tried in
patients

Compare strategies for
Develop funding
disseminating evidence from
incentives and RFAs
pre-clinical research to
targeted to promising
potentially receptive clinical
pre-clinical results that
research centers, funders,
encourage clinical
and other stakeholder
research uptake
partners

Translational research
In designing clinical research
centers within
intervention for trial, use
departments of
design methods to iteratively
academic medical
consider barriers to adoption
centers
among target patients and
organizations and modify

Clinical research
To have
to clinical
knowledge
implementation
about an
efficacious
intervention
in patients
evaluated in
practice

Provide funding
incentives and reduce
administrative and
human subjects
burdens to increase
receptivity for clinical
implementation
research

In designing clinical
Clinical and Practiceimplementation intervention
based research
for trial, engage clinical
networks and
stakeholders to identify
public health
barriers to adoption and
collaborations
modify; identify stakeholders
that can lead in adopting the
intervention in target
organizations

To have
Clinical
knowledge
implementation
about an
to public
effective
health
intervention
in practice
evaluated in
population

Compare strategies for
Develop partnerships
In research design, engage
disseminating clinical
with community
stakeholders in identifying
implementation evidence to
stakeholders, policyoptimal strategies for
optimize adoption by diverse
makers, and the
implementation
private sector that can
and representative end users
facilitate efficient rollout

Identify organizations that
could help disseminate the
intervention once proven
and co-create strategies for
disseminating the evidence
to optimize enrollment of
diverse and representative
practices

In designing pre-clinical
research intervention for
trial, consider barriers to
adoption of similar
interventions and modify

Team science
initiatives that
partner multidisciplinary basic
and clinical
scientists and
industry

Region-level
collaborations with
policymakers,
payers, advocacy
groups, health
systems, and public
health networks

D&I, dissemination and implementation; IFDIT, Integrative Framework of Dissemination, Implementation and Translation.

The framework reinforces the prevailing paradigm that health
interventions are first developed and evaluated (e.g. in basic,
pre-clinical, and clinical stages) and then implemented (e.g. in
clinical implementation and public health stages), but it includes
additional guidance on the role of the D&I sciences in both
activities. Specifically, the framework’s outer ring proposes that,
in early-stage research, questions of intervention viability and
efficacy should be prioritized, but that D&I principles should still
be applied in considering the intervention’s design, usability,
desirability, and potential for dissemination – a concept referred
to as “designing for D&I [14,23].” Conversely, in late-stage
research, questions concerning how best to disseminate and implement interventions should be prioritized and issues related to
effectiveness should only be explored pragmatically and as they
relate to the new circumstances in which the intervention finds
itself. The framework’s outer ring transitions from one focus to
the other (e.g. from intervention development and evaluation to
D&I) at the mid-point of the clinical research stage. This represents
the potential for hybrid effectiveness–implementation studies
that occur within this stage and simultaneously consider both
topics [24].
Finally, the IFDIT positions D&I sciences as “sub-sciences” of
translational science that are used, when appropriate, to contribute to the larger goal of translation. To that end, the framework
shows how understanding from and principles commonly associated with D&I sciences can be used to optimize processes both
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within and between all stages. This is best depicted in tables.
Table 2 provides examples of how D&I sciences and principles
can inform the conduct of research within a translational
stage. Table 3 provides examples of how D&I sciences and principles help to move research from one stage to the next. Clearly,
the most important and obvious role for D&I sciences is in supporting the uptake of research knowledge from one stage to
another (research application) and in the later stages of research
conduct. However, as shown in the tables, D&I sciences can help
improve the efficiency and quality of research conduct within
any stage.
Three Examples
To further highlight the ways in which D&I sciences can and do
support translation, we provide three diverse and illustrative examples. In the first example, no actual D&I research was conducted,
but rather translation was advanced through an understanding of
D&I processes and an application of D&I principles. In the second
example, implementation research was conducted to understand
barriers to adoption and to evaluate the effectiveness of implementation strategies. In the third example, D&I principles were used to
integrate parallel lines of inquiry to generate new evidence,
and stakeholder engagement was used to troubleshoot late-stage
translational barriers. In each example, we refer to key stages
and processes from the IFDIT framework.

Journal of Clinical and Translational Science

Example 1: Glycomacropeptide-Based Food for
Phenylketonuria
Individuals with phenylketonuria (PKU) cannot metabolize phenylalanine and thus must maintain their nutrition through a synthetic
amino acid formula-based diet that smells and tastes bitter and is
difficult to adhere to. Basic science research at the University of
Wisconsin resulted in the isolation of glycomacropeptide (GMP)
in 1999, a by-product of cheese-making with essentially no phenylalanine [25,26]. After isolation – and in an example of bidirectional
research application between stages – the research team reached out
to the National PKU Alliance to learn about the broader context and
potential desire by patients and families for development of GMPbased foods. This activity established the value of proceeding down
this line of research by confirming high stakeholder demand for the
product. A multi-stakeholder “GMP for PKU Task Force” was
formed at the university. This “team science” initiative was intended
to shorten the time required to move from pre-clinical research to
clinical implementation. A researcher in nutritional science was
recruited to lead mouse and human studies of GMP safety and comparative efficacy and, after finding positive results [26], the university’s Dairy Research Center was engaged to develop palatable GMPbased food products, exemplifying understanding of the multi-level
context and the need to quickly move from pre-clinical to clinical
research. After successfully developing several products, the research
team used pre-existing collaborative relationships with PKU
patients to facilitate recruitment of participants into clinical trials,
thus improving the process of study conduct during the clinical
research stage [25]. To support late-stage dissemination, a foundation with ties to the university provided commercialization support
and a small foods company started by a family with a child with PKU
took ownership of the license in 2010. Currently, this company’s
GMP-based foods make up 10% of the world market of medical
foods for PKU, improving adherence and quality of life for thousands of patients with PKU.
Example 2: Reducing Early Cardiovascular Mortality Risk in
Mental Health Populations
People with serious mental illness experience one of the nation’s
greatest but least well-recognized health disparities: an 11–25-year
reduction in life expectancy due to mainly cardiovascular causes.
Building on meta-analytic data leveraging “basic” data science
and demonstrating this disparity, a community-engaged partnership was formed with researchers at Dartmouth to co-develop and
evaluate the “In SHAPE” intervention, a “health mentor” program
with weekly coaching sessions and monthly motivational “celebrations.” Stakeholder engagement was critical in understanding the
multi-level context at this pre-clinical stage and to developing an
intervention that would be successful in engaging people with
mental illness and leaders of mental health provider organizations.
The effectiveness of In SHAPE was established in two randomized
controlled trials (RCTs) demonstrating a clinically significant
reduction in cardiovascular risk [27,28]. Broad uptake of the program by the public mental health sector was limited; however,
due to the fact that mental health organizations were not organized,
trained, staffed, or funded to provide health promotion and prevention interventions targeting cardiovascular risk factors. To address
these barriers to uptake, a statewide implementation research study
was designed to evaluate the effectiveness of a “learning community”
consisting of program leaders from New Hampshire’s 10 mental
health centers. The implementation strategy proved effective at
increasing the reach while maintaining the effectiveness of the
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intervention (approximately half of the participants experienced
clinically significant cardiovascular risk reductions [29]). To determine the most effective and feasible way to scale the intervention
more broadly, a national, randomized implementation study is currently underway within 48 mental health organizations. Half of the
organizations are participating in a virtual learning collaborative and
the other half are receiving individual technical assistance. By considering the diverse, multi-level contexts in which the intervention is
deployed, this research is able to understand whether, why, and to
what extent the intervention is adapted, and the resulting effects on
uptake and effectiveness.
Example 3: Bridging Animal and Human Research to
Maximize Brain Development
Animal studies in the late 1990s demonstrated a positive effect of
maternal nurturance on hippocampal growth and adaptation to
stress [30]. Relationships between animal researchers and human
researchers in the area of brain development prompted the
conduct of observational studies in humans. Insights from these
longitudinal neuroimaging studies, combined with insights from
additional animal research, suggested the presence of “sensitive
periods” in early childhood when the brain would be more powerfully impacted by environmental forces [31]. Independent of this
research, a parallel line of clinical investigation had validated and
described depression in the preschool period and resulted in the
development of parent–child psychotherapies. In an example of
bidirectional application of research knowledge between clinical
and basic research stages, Luby and colleagues bridged these two
lines of investigation by using neuroimaging and measures of brain
function to assess the effects of the psychotherapy on brain development and function [32]. This enabled researches to generate
evidence of effectiveness for the treatment and a rationale for broad
D&I. Unfortunately, and despite widespread support within
the medical center and department of psychiatry, the program
met contextual and policy barriers related to reimbursement
(the program was designed to be delivered in a cost-effective
way by master’s-level therapists, who could not be reimbursed).
In an example of stakeholder engagement and the proactive development of an effective implementation strategy, the investigator
team adapted the program to be delivered broadly in the school
setting and is preparing to evaluate this version of the program
in an RCT. Parallel efforts are underway to educate payers and
other stakeholders to support policy changes that will facilitate
delivery in clinical mental health settings as well.
Discussion
In this Special Communication, we sought to communicate the
relationship between translational science and the sciences of
D&I and to demonstrate a potential expanded role for D&I sciences within and across the spectrum of translational research. In
pursuit of this goal, we developed a framework and provided tables
and examples to clearly communicate the ways in which D&I sciences can and do support the translational process. The major
proposition of the framework is that it situates D&I sciences
as essential “sub-sciences” of translational science that can be
used to overcome specific barriers to the translational process.
Along these lines, the framework also describes two different and
equally necessary translational processes (research conduct and
research application). The assumption is that advancements in
translational science will need to occur both within and between
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translational research stages, and that these lines of inquiry may
need to distinguish themselves from one another. Additionally,
the framework provides, to our knowledge, the first clear examples
of the ways in which principles from D&I science can be extended to
support the earliest phases of translational research. Our tables do
not fully communicate the multi-directional nature of processes
and instead imply an overly linear journey from basic science to population health benefit. In reality, translational processes can begin
with observations at any stage, move in any direction, and skip
any stage. Our framework is a representation of our own ideas
and experiences and does not represent empirical findings.
However, we recommend that CTSAs have an opportunity to support its testing and subsequent refinement, confirmation, or refusal.
Indeed, the concepts outlined in this paper should be useful to
CTSAs and NCATS alike in helping to shape a coordinated agenda
for the advancement of translational science. Specifically, we recommend NCATS convene a working group to consider the implications of adopting this framework as a guiding model for the
activities of Domain Task Forces across the CTSA Consortia.
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